Atlas Trials

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Clinical trial NCT01082510 · UNKNOWN

Trial details

NCT number
NCT01082510
Sponsor
Urological Oncology Council of Northern Tokyo
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2010-01-01
Primary completion
2017-12-01
Enrollment
288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.